INKT vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

INKT

60.4
AI Score
VS
INKT Wins

CBIO

49.1
AI Score

Investment Advisor Scores

INKT

60score
Recommendation
BUY

CBIO

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric INKT CBIO Winner
Net Income -5.87M 153,942 CBIO
Operating Income -6.10M -152.63M INKT
ROE 41.8% 0.1% INKT
ROA -61.1% 0.1% CBIO
Total Assets 9.62M 240.29M CBIO
Cash 8.81M 213.19M CBIO
Current Ratio 1.23 6.56 CBIO
Free Cash Flow -3.89M -72.45M INKT

Relative Price Performance (Last 90 Days)

INKT 1M: -12.9% · 3M: +1.1% CBIO 1M: -10.0% · 3M: -24.3%

Current Technical Phase

INKT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $10.71

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 39

RSI (14): 39.2 · Price: $12.82

Fundamentals Snapshot

Metric INKT CBIO
Market Cap — —
Forward P/E -4.9 -4.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — 1.0%
Operating Margin 0.0% -14.3%
EPS -2.39 -7.62
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INKT is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.